Melaniq 2024, V20
Subject: F, 48 years old
Treatment: Melaniq®
2023, independent third-party study, performed by Bionos Biotech, S.L., Valencia, Spain
STAY INFORMED
Sign up for e-mail and get news and offers from the Oxford Biolabs® family of brands
By clicking Subscribe you agree to subscribe to our marketing communications and other promotions. Please refer to the company's Privacy Policy for details and your rights with respect to how Oxford Biolabs manages your personal data.'